The benefits of AmnioMatrix include:

• Provides a structure for cellular migration and proliferation
• Contains collagen types IV, V and VII which promote cellular differentiation and adhesion
• Known to be antiangiogenic
• Anti-inflammatory effect
• Bacteriostatic effect
• Anti-adhesive and supportive in preventing scarring
• Assists with pain and discomfort at affected site
• Known to be non-immunogenic and low in antigenicity
• Provision of a natural biological barrier

HCP-AmnioMatric- -Application Techniques

Application Techniques:

A. Inlay (Graft)

• The amniotic membrane is usually placed epithelial side up.
• Epithelium grows over the graft, securing itself to the basement membrane.
• The amniotic membrane is intended to act as a substrate or scaffold for epithelial cells to grow and is therefore incorporated into the host tissue (cornea or conjunctiva).

B. Overlay (Patch)

• Amniotic membrane is usually placed epithelial side down.
• Shallow corneal defects.
• Epithelium grows beneath the patch, which dissolves within a few weeks.
• Here the amniotic membrane functions essentially as a cover or a biological bandage ‘contact lens,’ protecting the underlying healing epithelial surface.
• The intention is for the membrane to fall off or be removed over a period of time.

C. Sandwich

• Support for deeper corneal ulcers.
• Fill the defect with layers of amniotic membrane, epithelial side up.
• Single sheet to secure the multiple layers over the top.
• Top layer can be epithelial side up or down.

For additional information on ICD-10 Codes, follow the link: ICD-10 Master Industry Table – National Department of Health

1. Dua HS, Gomes JA., King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Survey of Ophthalmology. 2004 Jan;49(1):51–77.
2. Ahn J-I, Jang I-K, Lee D-H, Seo Y-K, Yoon H-H, Shin Y-H, et al. A comparison of lyophilized amniotic membrane with cryopreserved amniotic membrane for the reconstruction of rabbit corneal epithelium. Biotechnology and Bioprocess Engineering. 2005;10(3):262–9.
3. Baradaran-Rafii A, Aghayan H-R, Arjmand B, Javadi M-A. Amniotic membrane transplantation. Journal of Ophthalmic & Vision Research. 2008;2(1):58–75.
4. Hao Y, Ma DH-K, Hwang DG, Kim W-S, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19(3):348–52.
5. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20(4):408–13.
6. Riau AK, Beuerman RW, Lim LS, Mehta JS. Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials. 2010 Jan;31(2):216–25.
7. Letko E, Stechschulte SU, Kenyon KR, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001;119(5):659-663.
8. Anderson DF, Ellies P, Pires RT, Tseng SC. Amniotic membrane transplantation for partial limbal stem cell deficiency. Br J Ophthalmol. 2001;85(5):567-575.
9. Pires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999;117(10):1291-1297.
10. Meallet MA, Espana EM, Grueterich M, Ti SE, Goto E, Tseng SC. Amniotic membrane transplantation with conjunctival limbal autograft for total limbal stem cell deficiency. Ophthalmology. 2003;110(8):1585-1592.
11. Anderson DF, Prabhasawat P, Alfonso E, Tseng SC. Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea. 2001;20(4):354-361.
12. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109(4):694-703.
13. Shanbhag SS, Rashad R, Chodosh J, Saeed HN. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Am J Ophthalmol. 2019;208:331-341.
14. Arora R, Mehta D, Jain V. Amniotic membrane transplantation in acute chemical burns. Eye (Lond). 2005;19(3):273-278.
15. Bissen-Miyajima H, Monden Y, Shimazaki J, Tsubota K. Cataract surgery combined with ocular surface reconstruction in patients with severe cicatricial keratoconjunctivitis. J Cataract Refract Surg. 2002;28(8):1379-1385.
16. Palamar M, Kaya E, Egrilmez S, Akalin T, Yagci A. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye (Lond). 2014;28(9):1131-1135.
17. Nagai-Kusuhara A, Nakamura M, Fujioka M, Negi A. Long-term results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):567-571.
18. Sarnicola V, Millacci C, Toro Ibanez P, Sarnicola C, Sarnicola E, Ruggiero A. Amniotic membrane transplantation in failed trabeculectomy. J Glaucoma. 2015;24(2):154-160.
19. Honavar SG, Bansal AK, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology. 2000;107(5):975-979.
20. Thatte S, Jain J. Fornix Reconstruction with Amniotic Membrane Transplantation: A Cosmetic Remedy for Blind Patients. J Ophthalmic Vis Res. 2016;11(2):193-197.
21. Slentz DH, Joseph SS, Nelson CC. The Use of Umbilical Amnion for Conjunctival Socket, Fornix, and Eyelid Margin Reconstruction. Ophthalmic Plast Reconstr Surg. 2020;36(4):365-371.
22. Ti SE, Tow SL, Chee SP. Amniotic membrane transplantation in entropion surgery. Ophthalmology. 2001;108(7):1209-1217.
23. Casas VE, Kheirkhah A, Blanco G, Tseng SC. Surgical approach for scleral ischemia and melt. Cornea. 2008;27(2):196-201.
24. Pan X, Zhang D, Jia Z, Chen Z, Su Y. Comparison of hyperdry amniotic membrane transplantation and conjunctival autografting for primary pterygium. BMC Ophthalmol. 2018;18(1):119.

Packaging

Storage